| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/03/1994 | CA2142602A1 Fungal promoters active in the presence of glucose |
| 03/03/1994 | CA2142456A1 Anti-microbial composition |
| 03/03/1994 | CA2142455A1 Method for systemic treatment of catabolic conditions and systemic tissue injury |
| 03/03/1994 | CA2142306A1 Cationic peptides and method for production |
| 03/03/1994 | CA2142305A1 Opioid receptor genes |
| 03/03/1994 | CA2142295A1 Methods useful in endotoxin prophylaxis and therapy |
| 03/03/1994 | CA2141861A1 Use of specific binding molecules in potentiating igf-i activity |
| 03/03/1994 | CA2141602A1 Use of the cytokine ip-10 as an anti-tumor agent |
| 03/03/1994 | CA2141598A1 Method of inhibiting cell proliferation using apolipoprotein e |
| 03/03/1994 | CA2141583A1 Insect viruses and their uses in protecting plants |
| 03/03/1994 | CA2141457A1 Cytokine applications |
| 03/03/1994 | CA2140908A1 Method of recovering endothelial membrane from tissue and applications thereof |
| 03/03/1994 | CA2140280A1 Bispecific immunoadhesins |
| 03/03/1994 | CA2120760A1 Peptide having allergenicity |
| 03/03/1994 | CA2117270A1 Use of bacillus thuringiensis isolates for controlling pests in the family aphididae |
| 03/02/1994 | EP0585201A1 Diagnostic test-kit for the determination of proteins |
| 03/02/1994 | EP0585155A1 Trifluoromethylketone derivatives of peptides having HLE inhibiting activity, their preparation and pharmaceutical composition |
| 03/02/1994 | EP0584854A1 Immunoassay using carbamazepine analogues labelled with horseraddish peroxidase |
| 03/02/1994 | EP0584845A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer |
| 03/02/1994 | EP0584788A2 Serum free medium for mammalian cells |
| 03/02/1994 | EP0584558A2 A composition for suppressing infection and growth of human immunodeficiency virus using an iron-binding protein |
| 03/02/1994 | EP0584552A2 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| 03/02/1994 | EP0584536A1 The glucose-regulated promoter of yeast acetyl-CoA hydrolase |
| 03/02/1994 | EP0584452A1 Novel amyloid precursor proteins and methods of using same |
| 03/02/1994 | EP0584446A2 Microsomal triglyceride transfer protein |
| 03/02/1994 | EP0584368A1 Cell adhesion inhibiting antibody and cell adhesion inhibitor containing the same |
| 03/02/1994 | EP0584348A1 Genetic vaccine for immunodeficiency viruses |
| 03/02/1994 | EP0584290A1 Endothelin antagonists |
| 03/02/1994 | EP0584287A1 Use of müllerian inhibiting substance for treatment of certain tumors |
| 03/02/1994 | EP0584286A1 Use of platelet derived growth factor in the preparation of a medicament for the treatment of gastrointestinal ulcers |
| 03/02/1994 | EP0584284A1 Recombinant dna-derived cholera toxin subunit analogs |
| 03/02/1994 | EP0584283A1 Osteoinductive protein mixtures and purification processes |
| 03/02/1994 | EP0584273A1 Antibody recognizing endothelial cell ligand for leukocyte cr3 |
| 03/02/1994 | EP0584266A1 Recombinant virus expressing carcinoembryonic antigen and methods of use thereof |
| 03/02/1994 | EP0584264A1 D-type cyclin and uses related thereto |
| 03/02/1994 | EP0584256A1 Method for detecting an localizing tissues having neurokinine 1 receptors |
| 03/02/1994 | EP0584251A1 Cytokine receptor targeted molecules for treatment of meoplastic cell growth |
| 03/02/1994 | EP0584247A1 Compositons for the treatment of chronic fatigue syndrome |
| 03/02/1994 | EP0584244A1 Peptide inhibitors of inflammation |
| 03/02/1994 | EP0584238A1 INHIBITOR OF NF-$g(k)B TRANSCRIPTIONAL ACTIVATOR AND USES THEREOF |
| 03/02/1994 | EP0584229A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND |
| 03/02/1994 | EP0584217A1 Rfkbp: a novel prolyl isomerase and rapamycin/fk506 binding protein |
| 03/02/1994 | EP0584214A1 Gene manipulation and expression using genomic elements |
| 03/02/1994 | EP0584201A1 Transmission-blocking vaccine against malaria |
| 03/02/1994 | EP0584194A1 Assays for inhibitors of leukocyte adhesion |
| 03/02/1994 | EP0584167A1 Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
| 03/02/1994 | EP0584136A1 Determination of motifs of peptides on mhc molecules |
| 03/02/1994 | EP0584082A1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
| 03/02/1994 | EP0584061A1 Control of milk secretion |
| 03/02/1994 | EP0527787B1 Method of predisposing mammals to accelerated tissue repair |
| 03/02/1994 | EP0489884B1 Method for treating colostrum by hydroxyapatite adsorption chromatography, an active fraction of colostrum thereby obtained, and a cellular medium containing same |
| 03/02/1994 | EP0470980B1 Synthetic peptides for an hiv-1 vaccine |
| 03/02/1994 | EP0402378B1 Conjugation of polymer to colony stimulating factor-1 |
| 03/02/1994 | EP0378604B1 1,1-dioxo-cephem-4-carbothiolic acid derivatives |
| 03/02/1994 | EP0371998B1 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 03/02/1994 | EP0347433B1 Recombinant antibody |
| 03/02/1994 | CN1083075A Linear peptides |
| 03/02/1994 | CN1083071A A process for recovering a recombinant protein, in biologically active form, from a solution containing inactive protein |
| 03/02/1994 | CN1082921A Monomeric platelet-derived growth factor and prevention of stenosis or restenosis |
| 03/02/1994 | CN1023901C Novel family of primate hematopoietic growth factors |
| 03/02/1994 | CN1023900C Process for preparing human primary fibrocyte growth factor |
| 03/01/1994 | US5290920 Method of purifying human epidermal growth factor |
| 03/01/1994 | US5290919 Physiological oxygen carrier, artificial blood |
| 03/01/1994 | US5290918 Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation |
| 03/01/1994 | US5290917 Interleukins |
| 03/01/1994 | US5290915 Glucose-free polypeptides |
| 03/01/1994 | US5290914 Hybrid diphtheria-B.t. pesticidal toxins |
| 03/01/1994 | US5290763 Ultrafiltration of proteins |
| 03/01/1994 | US5290699 Double mutants of bacteriorhodopsin |
| 03/01/1994 | US5290688 Preparation of exoantigens and vaccine for cattle |
| 03/01/1994 | US5290686 Insect cell culture of Autographa virus by genetic engineering |
| 03/01/1994 | US5290685 Method for separation and concentration of phosphopeptides |
| 03/01/1994 | CA2104998A1 Bone-related carboxypeptidase-like protein and process for its production |
| 03/01/1994 | CA2104997A1 Bone-related cadherin-like protein and process for its production |
| 03/01/1994 | CA2101599A1 Tri- and tetracyclic compounds |
| 03/01/1994 | CA1327330C Expression system comprising aspergillus niger pectin lyase i gene sequences |
| 03/01/1994 | CA1327329C Recombinant diphtheria toxin fragments |
| 03/01/1994 | CA1327312C Injectable composition for inductive bone repair |
| 03/01/1994 | CA1327311C Therapeutic antimicrobial polypeptides, their use and methods for preparation |
| 03/01/1994 | CA1327310C Process for enhancing milk yield in mammals and/or increasing the birth weight of their newborns and postnatal growth |
| 02/27/1994 | CA2103623A1 Novel recombinant dna, production of mink growth hormone, and a dna fragment used to express mink growth hormone gene and to secrete mink growth hormone |
| 02/24/1994 | DE4227892A1 New peptide derivs. of receptor for rhinovirus |
| 02/23/1994 | EP0584023A1 Mycobacteria DNA fragments, amplification primers, hybridization probes, reagents and detection process of mycobacteria |
| 02/23/1994 | EP0583917A1 Ampa-binding human GLuR4 receptors |
| 02/23/1994 | EP0583884A1 Megakaryocyte differentiation factor |
| 02/23/1994 | EP0583799A1 Monoclonal antibodies to ELAM-1 sialoglycoprotein antigen on the surface of activated endothelial cells |
| 02/23/1994 | EP0583794A1 Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects |
| 02/23/1994 | EP0583675A1 A method of producing hybrid-agricultural-chemical-producing microorganisms |
| 02/23/1994 | EP0583534A1 Liquid detergents containing a peptide aldehyde |
| 02/23/1994 | EP0583352A1 $i(IN VITRO) METHODS FOR DETERMINING $i(IN VIVO) THROMBOTIC EVENTS |
| 02/23/1994 | CN1082606A Genetically engineered attenuated viruses |
| 02/22/1994 | US5288931 Incubating isolated growth factor in alkaline buffer with low concentrations of chaotropic and reducing agents |
| 02/22/1994 | US5288856 Method of isolating acid-stable, biologically active proteins |
| 02/22/1994 | US5288855 Extracellular form of the human fibroblast growth factor receptor |
| 02/22/1994 | US5288854 Antiinflammatory agents |
| 02/22/1994 | US5288853 Binding to heparin-coupled chromatographic medium, eluting with aqueous calcium chloride, precipitating with glycine and sodium chloride, washing |
| 02/22/1994 | US5288852 Human tumor necrosis factor polypeptides |
| 02/22/1994 | US5288708 Purifying human, animal gastric juice; polypeptide having storng antistress action; treating many diseases |
| 02/22/1994 | US5288641 Herpes Simplex virus as a vector |
| 02/22/1994 | US5288640 Sequences containing the vpu gene and vectors therefore methods of preparation and use |